Get the Stockscreener App
2.79
1.48%
0.09
Aethlon Medical Inc stock is traded at $2.79, with a volume of 6,858.
It is up +1.48% in the last 24 hours and up +349.18% over the past month.
Aethlon Medical Inc is a medical therapeutic company focused on developing the Hemopurifier (HP), a clinical-stage investigational immunotherapeutic device designed to address unmet needs in oncology, life-threatening infectious diseases, organ transplantation and other disease states in which extracellular vesicles (EVs) contribute to disease progression. The Hemopurifier utilizes a proprietary lectin-based technology to bind and remove enveloped viruses and EVs from biological fluids. EVs have been associated with immune suppression, metastasis, and resistance to therapy in cancer, as well as progression of severe infectious diseases. The Company operates as a single reportable segment.
See More
Previous Close:
$2.70
Open:
$2.81
24h Volume:
6,858
Relative Volume:
0.01
Market Cap:
$1.98M
Revenue:
$574.20K
Net Income/Loss:
$-7.15M
P/E Ratio:
-0.1757
EPS:
-15.8778
Net Cash Flow:
$-7.00M
1W Performance:
-3.18%
1M Performance:
+349.18%
6M Performance:
+36.32%
1Y Performance:
+25.11%
1-Day Range:
$2.71
$2.81
1-Week Range:
$2.65
$3.06
52-Week Range:
$0.5079
$5.89
Aethlon Medical Inc Stock (AEMD) Company Profile
Name
Aethlon Medical Inc
Sector
Industry
Phone
619-941-0360
Address
11555 SORRENTO VALLEY ROAD, SUITE 203, SAN DIEGO, CA
Compare AEMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
AEMD
Aethlon Medical Inc
|
2.7899 | 1.98M | 574.20K | -7.15M | -7.00M | -15.88 |
ABT
Abbott Laboratories
|
114.68 | 198.01B | 46.59B | 5.41B | 7.38B | 3.0938 |
SYK
Stryker Corp
|
330.90 | 130.41B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
92.28 | 120.48B | 36.36B | 4.84B | 5.43B | 3.7261 |
BSX
Boston Scientific Corp
|
49.62 | 75.37B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
89.50 | 53.19B | 6.30B | 1.07B | 1.09B | 1.8406 |
Aethlon Medical Inc Stock (AEMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jul-07-25 | Resumed | H.C. Wainwright | Neutral |
Aethlon Medical Inc Stock (AEMD) Latest News
Aethlon (AEMD) Quarterly Results: The EPS Result Is Below Expectation in the Available Record; Price Reaction: The Stock Ends Down 3.81%Earnings Risk Report - Vinanet
Aethlon Medical at emerging growth conference: early cancer signal builds By Investing.com - Investing.com South Africa
Aethlon Medical at emerging growth conference: early cancer signal builds - Investing.com
Aethlon (AEMD) Watch: Trades in a Narrow Directional Range at $2.89; Immediate View: the Price Remains Bounded by the Supplied Support and Resistance on the DayAAII Bullish - Vinanet
Maxim Group Maintains Aethlon Medical(AEMD.US) With Hold Rating - Moomoo
H.C. Wainwright reiterates Aethlon Medical stock rating at Neutral By Investing.com - Investing.com South Africa
Aethlon (AEMD) Quarter in Review: EPS Comes in Below Forecast in the Available Record; Post-Report Move: Shares Finish 4.71% Down in the Latest ReadingAnnual Earnings Summary - Vinanet
Aethlon Medical (AEMD) Falls 3.7% to $2.83 as Support Level LoomsCollar Trade - Vinanet
AEMD Q2 2026 Earnings: Wider-than-Expected Loss of -$4.02 Per Share Highlights Clinical-Stage Challenges - Vinanet
Aethlon Medical, Inc. Q1 2027 Earnings Call Summary - Yahoo Finance
Aethlon Medical Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings call transcript: Aethlon Medical posts Q1 2026 loss miss as trial advances - Investing.com Nigeria
Aethlon Medical (AEMD) trims quarterly loss and raises $4M in new funding - Stock Titan
Aethlon Medical Q1 Results: EPS misses estimate, losses widen - scanx.trade
Aethlon Medical Advances Hemopurifier Trials and Bolsters Liquidity - TipRanks
AETHLON MEDICAL ($AEMD) Releases Q1 2027 Earnings - Quiver Quantitative
Aethlon Medical Reports Q1 Fiscal 2027 Results and Progress on Hemopurifier® Program - marketscreener.com
Aethlon Medical (AEMD) investors disclose 55,556-share warrant position, 2.3% stake - Stock Titan
Q3 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Q1 2026 Aethlon Medical Inc Earnings Call Transcript - GuruFocus
Asset turnover of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Inventory turnover of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Total assets of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Diluted shares outstanding of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
Net income before discontinued operations of Aethlon Medical, Inc. – LS:A42HQZ - TradingView
AEMD Q2 2026 Earnings: Narrower Loss Beats Estimates, Shares Rise 3.75%High Estimate Range - Vinanet
AEMD Q1'26 Earnings: EPS estimate is (3.92) USD - TradingView
Aethlon Medical Inc expected to post a loss of 78 cents a shareEarnings Preview - TradingView
Aethlon Medical (AEMD.US) will release its earnings report after market close on August 13. - Moomoo
Stock splits calendar for: - Yahoo Finance UK
Aethlon Medical schedules Aug. 13 call on quarter ended June 30 - Stock Titan
Stock Splits Calendar for: - Yahoo! Finance Canada
Market Movers | Winners: AEMD, HYFM, FUSE | Losers: GYGY, CALC, MIRA - Trefis
Calendrier des fractionnements d'actions pour: - Yahoo Finance France
Aethlon Medical To Carry Out 1-for-5 Reverse Stock Split On August 4th, 2026 - Moomoo
AEMD Q2 2026 Earnings: Narrower-Than-Expected Loss Boosts Shares 17%Earnings Acceleration Picks - Vinanet
Aethlon Medical Announces Reverse Stock Split Implementation - TipRanks
Aethlon Medical, Inc. Announces 1-for-5 Reverse Stock Split Effective July 30, 2026 - Minichart
Aethlon Medical (AEMD) Holds Steady Near Support as Trading Volume Remains SubduedBlue Chip Entry Points - Vinanet
Aethlon Medical Inc (AEMD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
TradingKey - TradingKey
Aethlon Medical, Inc. Revenue Breakdown – NASDAQ:AEMD - TradingView
AEMD Q2 2026 Earnings: Narrower-Than-Expected Loss Per ShareAnnual Earnings Summary - Vinanet
Aethlon Medical (AEMD) Dips 3.4% to $0.63 as Small-Cap Biotech Faces Persistent Selling PressureIntraday Profile - dars.gov.et
AETHLON MEDICAL INC (AEMD) Stock Chart - ChartMill
Aethlon Medical (AEMD) Slips 1.5% as Stock Tests Key Support at $0.63Time Weighted Price - Vinanet
Aethlon Medical at emerging growth conference: trial data and cash boost - Investing.com
AEMD: Hemopurifier shows early promise in oncology trials, with strong platform and financial position - TradingView
Aethlon Medical Reports Encouraging Hemopurifier Trial Results - t.co
Aethlon Medical (AEMD) Gains 2.39% as Stock Approaches $0.70 Resistance LevelSupport Level Bounce - dars.gov.et
Aethlon Medical reports second cohort results from cancer study - Investing.com UK
Aethlon Medical Inc Stock (AEMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.59%
0.75%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):